Novartis AG is 33.9x more valuable than CYTOKINETICS INC by market capitalization ($283.13 B vs $8.35 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CYTK | NVS |
|---|---|---|
| Market cap | $8.35 B | $283.13 B |
| US-listed rank | #1044 | #47 |
| Revenue (latest FY) | $88.04M | - |
| Net income (latest FY) | -$784.96M | - |
| Net margin | -891.6% | - |
| SEC filings | 2,450 | 947 |
Novartis AG is 33.9x more valuable than CYTOKINETICS INC by market capitalization ($283.13 B vs $8.35 B).
Full pages: CYTOKINETICS INC and Novartis AG, or browse the full rankings.